Innovative Algorithm for Incidence of Leukemia and Lymphoma in the U.S. Military Health Care System
Scott W. Penney(Brooke Army Medical Center), Lauren M. Vasta(Uniformed Services University of the Health Sciences), Daniel I. Brooks(Walter Reed National Military Medical Center), Nora L. Watson(Walter Reed National Military Medical Center), Richard Zanetti(Uniformed Services University of the Health Sciences), Anne B. Warwick(Uniformed Services University of the Health Sciences), Susan L. Whiteway(Uniformed Services University of the Health Sciences)
Cited by 2
Related Papers
Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT
|Bone Marrow Transplantation|2018|104
Comparative Effectiveness of Levothyroxine, Desiccated Thyroid Extract, and Levothyroxine+Liothyronine in Hypothyroidism
|The Journal of Clinical Endocrinology & Metabolism|2021|90
Mifamurtide in metastatic and recurrent osteosarcoma: A patient access study with pharmacokinetic, pharmacodynamic, and safety assessments
|Pediatric Blood & Cancer|2013|73
Inhibition of cyclin-dependent kinase 6 suppresses cell proliferation and enhances radiation sensitivity in medulloblastoma cells
|Journal of Neuro-Oncology|2012|67
Long-Term Survival and Late Effects among One-Year Survivors of Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Acute Leukemia and Myelodysplastic Syndromes
|Biology of Blood and Marrow Transplantation|2014|65